# Contact — Retatrutide Safe editorial

> Editorial contact for Retatrutide Safe. Corrections, citation requests, and references to recent peer-reviewed publications welcome. Not for medical questions.

Corrections and references to new peer-reviewed literature are welcome. We do not answer medical questions and we do not provide treatment guidance.

## What we can help with

We respond to two kinds of message.

**Corrections.** If a citation on this site is mis-attributed, a number is misreported, a publication has been retracted, or a more recent peer-reviewed paper supersedes a finding we summarise, please tell us. Include the page, the specific sentence, and the corrected source. Corrections are reviewed against the underlying publication and applied promptly.

**Citation suggestions.** New peer-reviewed retatrutide literature, additional TRIUMPH program readouts, and supplementary trial analyses are welcome. Include the DOI or PubMed/PMC identifier and a one-sentence note on what the paper adds.

For either type of message, please use the form below or write to the editorial address indicated. We do not guarantee a personal reply to every message but we do read everything.

## What we cannot help with

We cannot provide medical advice. We cannot answer questions about whether retatrutide is appropriate for a particular person, condition, or set of circumstances. We cannot recommend a dose, a titration schedule, or a duration of use. We cannot refer to a clinician, a clinical trial enrolment site, or a supplier.

For medical questions, please consult a licensed clinician in your jurisdiction. For information about enrolling in a retatrutide clinical trial, search the ClinicalTrials.gov registry directly using the relevant NCT identifier (for example, NCT05929066 for TRIUMPH-1 or NCT05882045 for TRIUMPH-3) and follow the contact details listed for the study sites.

This site does not sell, supply, or distribute any product and is not affiliated with any vendor or manufacturer.

## Contact form

Please use the form to send a message. Include the page URL where relevant and a DOI or PubMed/PMC link for any cited source. All submissions are editorial; we do not share submitter information with third parties.

This site is an independent editorial digest of the published research literature — not a clinic, not a vendor, not a source of medical guidance.

---

A primary-literature monitor for an investigational compound — not a clinic, not a vendor, not a clinical recommendation.